InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: BonelessCat post# 75400

Thursday, 10/17/2013 7:29:36 AM

Thursday, October 17, 2013 7:29:36 AM

Post# of 146240
Thank you BigKahuna. The article linked to your post is very encouraging for the remainder of 2013 and should help build anticipation for 2014, the year of the "shifting-paradigm of antiviral drugs", NanoViricides, Inc.

Nanoviricides: A New Hero in Antiviral Science

Revolutionizing the archaic vaccine system.
http://www.bu.edu/synapse/2011/11/27/nanoviricides/

"As a nation that has always prided itself on being at the forefront of progress, the reality is that the United States has reached a point of stagnation regarding the development of the current vaccine system. The U.S. is losing ground and needs to act quickly in the face of growing viral diseases and unfortunately, the present vaccine system doesn’t allow for this. With more research and development, the United States can support and look forward to the development of better, safer vaccines that allow us to battle disease on its own terms. Nanoviricides present a compelling war plan.

We would like to thank the CEO of NanoViricides, Eugene Seymour, for kindly agreeing to provide input and insight on this article."

Excerpt from 2009 Jain Report: Structure and function of nanoviricides

source: http://allallan.blogspot.com/2009/04/nnvc-why-so-special.html

Advantages of NanoViricides

§ The biological efficacy of NanoViricides drugs may be several orders of magnitude better than that of of usual chemical drugs. This in itself may limit the potential for mutant generation.

§ Low cost of drug development, manufacture, distribution.

more: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=91021791
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News